infectious diseases
empiric antibiotic therapy
6- community-acquired pneumonia wip severity-stratified empiric therapy by CURB-65; β-lactam + macrolide vs fluoroquinolone; short-course evidence5 min 2026-08-23
- urinary tract infections wip cystitis vs pyelonephritis vs complicated UTI; outpatient vs inpatient empirics; ASB pitfalls5 min 2026-08-23
- skin and soft tissue infections wip purulent vs non-purulent classification; cellulitis, abscess, necrotising fasciitis; MRSA decision-making5 min 2026-08-23
- intra-abdominal infections wip source control primacy; community vs healthcare-associated empirics; STOP-IT duration evidence5 min 2026-08-23
- bacterial meningitis wip time-critical empirics; dexamethasone timing; CSF interpretation; *Listeria* cover indications5 min 2026-08-23
- sepsis of unknown source wip undifferentiated sepsis empirics; source identification approach; resuscitation targets; de-escalation6 min 2026-08-23
coming soon
0 + 4 planned- *Clostridioides difficile* infection planned
- infective endocarditis planned
- osteomyelitis / septic arthritis planned
- HIV opportunistic infections planned